BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 29
• 30

• Biotech Bay

  Counsyl Highlights Importance of Patient Access to Genetic Testing at the 2018 ACMG Annual Clinical Genetics Meeting

  Counsyl leaders will offer TED-style talk, two platform presentations and two posters at the conference, and will host a CME satellite symposium focused on improving workforce efficiency in genetics

  April 4, 2018

   · 

  4 min read
• Deals

  Tekni-Plex acquires Dunn Industries, expands extruded medical tubing portfolio

  Tekni-Plex, Inc. has acquired Dunn Industries, Inc., a manufacturer of specialty extrusion tubing for medical device applications.

  April 4, 2018

   · 

  2 min read
• Business

  Axxess Bolsters Senior Leadership Team with Two New Hires

  Industry Veteran Tim Ingram and Engineering and Marketing Specialist Dennis Taylor Add Operational Strength

  April 4, 2018

   · 

  1 min read
• Business

  Agilent and BioTek Join Forces to Create an Integrated Metabolic Analysis and Imaging Platform

  Agilent Technologies Inc. (NYSE: A) and BioTek Instruments, Inc. today announced a new, integrated solution that combines cellular metabolic analysis and imaging technologies.

  April 4, 2018

   · 

  3 min read
• Business

  Baxter to Host First Quarter 2018 Financial Results Conference Call for Investors

  Baxter International, Inc. will host a conference call to discuss its first quarter 2018 financial results on Thursday, April 26, 2018, at 7:30 a.m. Central Daylight Time.

  April 4, 2018

   · 

  1 min read
• Business

  Lilly Confirms Date and Conference Call for First-Quarter 2018 Financial Results Announcement

  Eli Lilly and Company will announce its financial results for the first quarter of 2018 on Tuesday, April 24, 2018.

  April 4, 2018

   · 

  1 min read
• 

  Business

  Roche Acquires Inception 5 MS Program, Versant Forms New Company

  Building on a four-year-old relationship Roche struck a deal to acquire a regenerative therapy program for multiple sclerosis from Inception Sciences, a drug discovery engine co-founded with Versant Ventures in 2011.

  April 4, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  BioCapital

  Drugs That Are Likely to Fall Off the Patent Cliff This Year

  If a brand name drug loses patent protection, that often marks the date when companies can begin marketing generic versions of the drug. However, this has grown more complicated with the approvals of biosimilars.

  April 4, 2018

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Eli Lilly’s Cyramza Succeeds in Phase III Trial

  Eli Lilly and Company announced top-line data from its Phase III REACH-2 trial of Cyramza (ramucirumab) as a monotherapy second-line treatment for hepatocellular carcinoma (HCC), which is liver cancer.

  April 4, 2018

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Eli Lilly Plunks Down $63M Upfront in Deal With Startup Sigilon

  Less than one year after it launched Cambridge, Mass.-based startup Sigilon Therapeutics struck a collaboration deal with Eli Lilly to develop encapsulated cell therapies for the potential treatment of type 1 diabetes.

  April 4, 2018

   · 

  2 min read

   · 

  Alex Keown